trial · primary record
liposomal doxorubicin
Kaposi Sarcoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 62 |
| Primary completion | 2029-01-01 |
| Primary endpoint | safety/tolerability of dose combinations |
| Registry ID | NCT02659930 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:58.724Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02659930
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.